Skip to main content
SpringerLink
Log in

Fertility in the Adolescent and Young Adult Patient with Cancer

  • Chapter
  • First Online:
A Practical Approach to the Care of Adolescents and Young Adults with Cancer

Abstract

In recent years significant progress in cancer therapy has led to vastly improved survival rates in the adolescent and young adult diagnosed with cancer. Many patients receive treatment that results in the loss or compromise of future fertility. This has led to a greater focus on reproduction as an important aspect of survivorship. The simultaneous advances in assisted reproductive technology has meant that young people have a better opportunity for future fertility. Though national and international guidance recommend discussion and provision of fertility preservation where practicable there is considerable variation in clinical practice. Oncofertility centres set up in association with larger cancer centres has enabled a rapid access to specialist fertility services, and long term care of gonadal dysfunction in young cancer patients. It is hoped that development of oncofertility networks in the future will enable these resources to be accessed by all cancer centres and many more young people to avail of these services. In this chapter we provide a comprehensive understanding of the effect of cancer therapy on fertility and options of fertility preservation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. O’Hara C, Moran A, Whelan JS, Hough RE, Stiller CA, Stevens MC, Stark DP, Feltbower RG, McCabe MG. Trends in survival for teenagers and young adults with cancer in the UK 1992-2006. Eur J Cancer. 2015;51(14):2039–48.

    Article  PubMed  PubMed Central  Google Scholar 

  2. CRUK, R. o. t. i. c. t. Achieving world class cancer outcomes—a strategy for england 2015–2020. 2015. http://www.cancerresearchuk.org/sites/default/files/achieving_world-class_cancer_outcomes_-_a_strategy_for_england_2015-2020.pdf.

  3. NHSEngland. NHS standard contract for cancer: teenagers and young adults. 2013. https://www.england.nhs.uk/wp-content/uploads/2013/09/b17.pdf.

  4. NICE, c. g.-. (2013). “Fertility: assessment and treatment for people with fertility problems.” NICE Clinical Guideline 156 guidance.nice.org.uk/cg156.

  5. Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, Quinn G, Wallace WH, Oktay K, American Society of Clinical. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(19):2500–10.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Salsman JM, Yanez B, Smith KN, Beaumont JL, Snyder MA, Barnes K, Clayman ML. Documentation of fertility preservation discussions for young adults with cancer: examining compliance with treatment guidelines. J Natl Compr Canc Netw. 2016;14(3):301–9.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Adams E, Hill E, Watson E. Fertility preservation in cancer survivors: a national survey of oncologists’ current knowledge, practice and attitudes. Br J Cancer. 2013;108(8):1602–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Ben-Aharon I, Abir R, Perl G, Stein J, Gilad G, Toledano H, Elitzur S, Avrahami G, Ben-Haroush A, Oron G, Freud E, Kravarusic D, Ben-Arush M, Herzel G, Yaniv I, Stemmer SM, Fisch B, Ash S. Optimizing the process of fertility preservation in pediatric female cancer patients - a multidisciplinary program. BMC Cancer. 2016;16:620.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Louwe LA, Stiggelbout AM, Overbeek A, Hilders CG, van den Berg MH, Wendel E, van Dulmen-den Broeder E, Ter Kuile MM. Factors associated with frequency of discussion of or referral for counselling about fertility issues in female cancer patients. Eur J Cancer Care (Engl). 2016.

    Google Scholar 

  10. Nielsen CT, Skakkebaek NE, Richardson DW, Darling JA, Hunter WM, Jorgensen M, Nielsen A, Ingerslev O, Keiding N, Muller J. Onset of the release of spermatozoa (spermarche) in boys in relation to age, testicular growth, pubic hair, and height. J Clin Endocrinol Metab. 1986;62(3):532–5.

    Article  CAS  PubMed  Google Scholar 

  11. Schaefer F, Marr J, Seidel C, Tilgen W, Scharer K. Assessment of gonadal maturation by evaluation of spermaturia. Arch Dis Child. 1990;65(11):1205–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Keene DJ, Sajjad Y, Makin G, Cervellione RM. Sperm banking in the United Kingdom is feasible in patients 13 years or older with cancer. J Urol. 2012;188(2):594–7.

    Article  PubMed  Google Scholar 

  13. Bahadur G, Ling KL, Hart R, Ralph D, Wafa R, Ashraf A, Jaman N, Mahmud S, Oyede AW. Semen quality and cryopreservation in adolescent cancer patients. Hum Reprod. 2002;17(12):3157–61.

    Article  CAS  PubMed  Google Scholar 

  14. Hagenas I, Jorgensen N, Rechnitzer C, Sommer P, Holm M, Schmiegelow K, Daugaard G, Jacobsen N, Juul A. Clinical and biochemical correlates of successful semen collection for cryopreservation from 12-18-year-old patients: a single-center study of 86 adolescents. Hum Reprod. 2010;25(8):2031–8.

    Article  PubMed  Google Scholar 

  15. Kamischke A, Jurgens H, Hertle L, Berdel WE, Nieschlag E. Cryopreservation of sperm from adolescents and adults with malignancies. J Androl. 2004;25(4):586–92.

    Article  PubMed  Google Scholar 

  16. Rowley MJ, Leach DR, Warner GA, Heller CG. Effect of graded doses of ionizing radiation on the human testis. Radiat Res. 1974;59(3):665–78.

    Article  CAS  PubMed  Google Scholar 

  17. Petersen PM, Skakkebaek NE, Vistisen K, Rorth M, Giwercman A. Semen quality and reproductive hormones before orchiectomy in men with testicular cancer. J Clin Oncol. 1999;17(3):941–7.

    Article  CAS  PubMed  Google Scholar 

  18. Agarwal A, Allamaneni SS. Disruption of spermatogenesis by the cancer disease process. J Natl Cancer Inst Monogr. 2005;34:9–12.

    Article  Google Scholar 

  19. Rueffer U, Breuer K, Josting A, Lathan B, Sieber M, Manzke O, Grotenhermen FJ, Tesch H, Bredenfeld H, Koch P, Nisters-Backes H, Wolf J, Engert A, Diehl V. Male gonadal dysfunction in patients with Hodgkin’s disease prior to treatment. Ann Oncol. 2001;12(9):1307–11.

    Article  CAS  PubMed  Google Scholar 

  20. Williams DH t, Karpman E, Sander JC, Spiess PE, Pisters LL, Lipshultz LI. Pretreatment semen parameters in men with cancer. J Urol. 2009;181(2):736–40.

    Article  PubMed  Google Scholar 

  21. Ferreira U, Netto Junior NR, Esteves SC, Rivero MA, Schirren C. Comparative study of the fertility potential of men with only one testis. Scand J Urol Nephrol. 1991;25(4):255–9.

    Article  CAS  PubMed  Google Scholar 

  22. Apperley JF, Reddy N. Mechanism and management of treatment-related gonadal failure in recipients of high dose chemoradiotherapy. Blood Rev. 1995;9(2):93–116.

    Article  CAS  PubMed  Google Scholar 

  23. Colpi GM, Contalbi GF, Nerva F, Sagone P, Piediferro G. Testicular function following chemo-radiotherapy. Eur J Obstet Gynecol Reprod Biol. 2004;113(Suppl 1):S2–6.

    Article  CAS  PubMed  Google Scholar 

  24. Paoli D, Rizzo F, Fiore G, Pallotti F, Pulsoni A, Annechini G, Lombardo F, Lenzi A, Gandini L. Spermatogenesis in Hodgkin’s lymphoma patients: spermatogenesis in Hodgkin’s lymphoma patientsa retrospective study of semen quality before and after different chemotherapy regimens. Hum Reprod. 2016;31(2):263–72.

    CAS  PubMed  Google Scholar 

  25. Sieniawski M, Reineke T, Nogova L, Josting A, Pfistner B, Diehl V, Engert A. Fertility in male patients with advanced Hodgkin lymphoma treated with BEACOPP: a report of the German Hodgkin study group (GHSG). Blood. 2008;111(1):71–6.

    Article  CAS  PubMed  Google Scholar 

  26. Behringer K, Mueller H, Goergen H, Thielen I, Eibl AD, Stumpf V, Wessels C, Wiehlputz M, Rosenbrock J, Halbsguth T, Reiners KS, Schober T, Renno JH, von Wollff M, van der Ven K, Huehr M, Fuchs M, Diehl V, Engert A, Borchmann P. Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials. J Clin Oncol. 2013;31(2):231–9.

    Article  CAS  PubMed  Google Scholar 

  27. Choudhury RC, Jagdale MB, Misra S. Cytogenetic toxicity of cisplatin in bone marrow cells of Swiss mice. J Chemother. 2000a;12(2):173–82.

    Article  CAS  PubMed  Google Scholar 

  28. Choudhury RC, Jagdale MB, Misra S. Potential transmission of the cytogenetic effects of cisplatin in the male germline cells of Swiss mice. J Chemother. 2000b;12(4):352–9.

    Article  CAS  PubMed  Google Scholar 

  29. Frias S, Van Hummelen P, Meistrich ML, Lowe XR, Hagemeister FB, Shelby MD, Bishop JB, Wyrobek AJ. NOVP chemotherapy for Hodgkin’s disease transiently induces sperm aneuploidies associated with the major clinical aneuploidy syndromes involving chromosomes X, Y, 18, and 21. Cancer Res. 2003;63(1):44–51.

    CAS  PubMed  Google Scholar 

  30. Robbins WA, Meistrich ML, Moore D, Hagemeister FB, Weier HU, Cassel MJ, Wilson G, Eskenazi B, Wyrobek AJ. Chemotherapy induces transient sex chromosomal and autosomal aneuploidy in human sperm. Nat Genet. 1997;16(1):74–8.

    Article  CAS  PubMed  Google Scholar 

  31. Meistrich ML. Effects of chemotherapy and radiotherapy on spermatogenesis in humans. Fertil Steril. 2013;100(5):1180–6.

    Article  CAS  PubMed  Google Scholar 

  32. Martin RH, Ernst S, Rademaker A, Barclay L, Ko E, Summers N. Analysis of sperm chromosome complements before, during, and after chemotherapy. Cancer Genet Cytogenet. 1999;108(2):133–6.

    Article  CAS  PubMed  Google Scholar 

  33. Rives N, Walschaerts M, Setif V, Hennebicq S, Saias J, Brugnon F, Auger J, Berthaut I, Szerman E, Daudin M, Bujan L. Sperm aneuploidy after testicular cancer treatment: data from a prospective multicentre study performed within the French Centre d’Etude et de conservation des Oeufs et du Sperme network. Fertil Steril. 2017;107(3):580–8.

    Article  PubMed  Google Scholar 

  34. Brandriff BF, Meistrich ML, Gordon LA, Carrano AV, Liang JC. Chromosomal damage in sperm of patients surviving Hodgkin’s disease following MOPP (nitrogen mustard, vincristine, procarbazine, and prednisone) therapy with and without radiotherapy. Hum Genet. 1994;93(3):295–9.

    Article  CAS  PubMed  Google Scholar 

  35. Martinez G, Walschaerts M, Le Mitouard M, Borye R, Thomas C, Auger J, Berthaut I, Brugnon F, Daudin M, Moinard N, Ravel C, Saias J, Szerman E, Rives N, Hennebicq S, Bujan L. Impact of Hodgkin or non-Hodgkin lymphoma and their treatments on sperm aneuploidy: a prospective study by the French CECOS network. Fertil Steril. 2017;107(2):341–350.e5. https://doi.org/10.1016/j.fertnstert.2016.10.001. Epub 2016 Oct 31

    Article  PubMed  Google Scholar 

  36. Tempest HG, Ko E, Chan P, Robaire B, Rademaker A, Martin RH. Sperm aneuploidy frequencies analysed before and after chemotherapy in testicular cancer and Hodgkin’s lymphoma patients. Hum Reprod. 2008;23(2):251–8.

    Article  CAS  PubMed  Google Scholar 

  37. Hansen PV, Trykker H, Svennekjaer IL, Hvolby J. Long term recovery of spermatogenesis after radiotherapy in patients with testicular cancer. Radiother Oncol. 1990;18(2):117–25.

    Article  CAS  PubMed  Google Scholar 

  38. Anserini P, Chiodi S, Spinelli S, Costa M, Conte N, Copello F, Bacigalupo A. Semen analysis following allogeneic bone marrow transplantation. Additional data for evidence-based counselling. Bone Marrow Transplant. 2002;30(7):447–51.

    Article  CAS  PubMed  Google Scholar 

  39. Centola GM, Keller JW, Henzler M, Rubin P. Effect of low-dose testicular irradiation on sperm count and fertility in patients with testicular seminoma. J Androl. 1994;15(6):608–13.

    CAS  PubMed  Google Scholar 

  40. Kinsella TJ, Trivette G, Rowland J, Sorace R, Miller R, Fraass B, Steinberg SM, Glatstein E, Sherins RJ. Long-term follow-up of testicular function following radiation therapy for early-stage Hodgkin’s disease. J Clin Oncol. 1989;7(6):718–24.

    Article  CAS  PubMed  Google Scholar 

  41. Sandeman TF. The effects of x irradiation on male human fertility. Br J Radiol. 1966;39(468):901–7.

    Article  CAS  PubMed  Google Scholar 

  42. Sanders JE, Hawley J, Levy W, Gooley T, Buckner CD, Deeg HJ, Doney K, Storb R, Sullivan K, Witherspoon R, Appelbaum FR. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood. 1996;87(7):3045–52.

    CAS  PubMed  Google Scholar 

  43. Petersen PM, Giwercman A, Daugaard G, Rørth M, Petersen JH, Skakkeaek NE, Hansen SW, von der Maase H. Effect of graded testicular doses of radiotherapy in patients treated for carcinoma-in-situ in the testis. J Clin Oncol. 2002;20(6):1537–43.

    Google Scholar 

  44. Brauner R, et al. Leydig cell function in children after direct testicular irradiation for acute lymphoblastc leukaemia. N Engl J Med. 1983;309:25–8.

    Article  CAS  PubMed  Google Scholar 

  45. Sklar CA, Robison LL, Nesbit ME, Sather HN, Meadows AT, Ortega JA, Kim TH, Hammond GD. Effects of radiation on testicular function in long-term survivors of childhood acute lymphoblastic leukemia: a report from the Children Cancer Study Group. J Clin Oncol. 1990;8(12):1981–7.

    Article  CAS  PubMed  Google Scholar 

  46. Wang JH, Muller CH, Lin K. Optimizing fertility preservation for pre- and postpubertal males with cancer. Semin Reprod Med. 2013;31(4):274–85.

    Article  CAS  PubMed  Google Scholar 

  47. Bunge RG, Sherman JK. Fertilizing capacity of frozen human spermatozoa. Nature. 1953;172(4382):767–8.

    Article  CAS  PubMed  Google Scholar 

  48. Ragni G, Somigliana E, Restelli L, Salvi R, Arnoldi M, Paffoni A. Sperm banking and rate of assisted conception treatment indights from a 15 year cryopreservation programme for male cancer patients. Cancer. 2003;97:1624–9.

    Article  PubMed  Google Scholar 

  49. Roque M, Sampaio M, Salles PG, Geber S. Onco-testicular sperm extraction: Birth of a healthy baby after fertility preservation in synchronous bilateral testicular cancer and azoospermia. Andrologia. 2015;47(4):482–5.

    Article  CAS  PubMed  Google Scholar 

  50. Onofre J, Baert Y, Faes K, Goossens E. Cryopreservation of testicular tissue or testicular cell suspensions: a pivotal step in fertility preservation. Hum Reprod Update. 2016;22(6):744–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Wallace EM, Groome NP, Riley SC, Parker AC, Wu FC. Effects of chemotherapy-induced testicular damage on inhibin, gonadotropin, and testosterone secretion: a prospective longitudinal study. J Clin Endocrinol Metab. 1997;82(9):3111–5.

    Article  CAS  PubMed  Google Scholar 

  52. Gandini L, Lombardo F, Lenzi A, Spano M, Dondero F. Cryopreservation and sperm DNA integrity. Cell Tissue Bank. 2006;7(2):91–8.

    Article  CAS  PubMed  Google Scholar 

  53. Spermon JR, Ramos L, Wetzels AM, Sweep CG, Braat DD, Kiemeney LA, Witjes JA. Sperm integrity pre- and post-chemotherapy in men with testicular germ cell cancer. Hum Reprod. 2006;21(7):1781–6.

    Article  CAS  PubMed  Google Scholar 

  54. Gunnes MW, Lie RT, Bjorge T, Ghaderi S, Ruud E, Syse A, Moster D. Reproduction and marriage among male survivors of cancer in childhood, adolescence and young adulthood: a national cohort study. Br J Cancer. 2016;114(3):348–56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Huddart RA, Norman A, Moynihan C, Horwich A, Parker C, Nicholls E, Dearnaley DP. Fertility, gonadal and sexual function in survivors of testicular cancer. Br J Cancer. 2005;93(2):200–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Clowse ME, Behera MA, Anders CK, Copland S, Coffman CJ, Leppert PC, Bastian LA. Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis. J Womens Health (Larchmt). 2009;18(3):311–9.

    Article  Google Scholar 

  57. Schrader M, Muller M, Straub B, Miller K. The impact of chemotherapy on male fertility: a survey of the biologic basis and clinical aspects. Reprod Toxicol. 2001;15(6):611–7.

    Article  CAS  PubMed  Google Scholar 

  58. Green DM, Fiorello A, Zevon MA, Hall B, Seigelstein N. Birth defects and childhood cancer in offspring of survivors of childhood cancer. Arch Pediatr Adolesc Med. 1997;151(4):379–83.

    Article  CAS  PubMed  Google Scholar 

  59. Hassold T, Abruzzo M, Adkins K, Griffin D, Merrill M, Millie E, Saker D, Shen J, Zaragoza M. Human aneuploidy: incidence, origin, and etiology. Environ Mol Mutagen. 1996;28(3):167–75.

    Article  CAS  PubMed  Google Scholar 

  60. Garcia A, Herrero MB, Holzer H, Tulandi T, Chan P. Assisted reproductive outcomes of male cancer survivors. J Cancer Surviv. 2015;9(2):208–14.

    Article  PubMed  Google Scholar 

  61. Hsiao W, Stahl PJ, Osterberg EC, Nejat E, Palermo GD, Rosenwaks Z, Schlegel PN. Successful treatment of postchemotherapy azoospermia with microsurgical testicular sperm extraction: the Weill Cornell experience. J Clin Oncol. 2011;29(12):1607–11.

    Article  PubMed  Google Scholar 

  62. Kopeika J, Khalaf Y, Reddy N. ESHRE poster 2014. http://www.posters2view.eu/eshre2014/view.php?nu=282

  63. Wallace WH, Kelsey TW. Human ovarian reserve from conception to the menopause. PLoS One. 2010;5(1):e8772.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Faddy M, Gosden R. Numbers of ovarian follicles and testing germ line renewal in the postnatal ovary: facts and fallacies. Cell Cycle. 2007;6(15):1951–2.

    Article  CAS  PubMed  Google Scholar 

  65. Faddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod. 1992;7(10):1342–6.

    Article  CAS  PubMed  Google Scholar 

  66. Wallace WH, Thomson AB, Saran F, Kelsey TW. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys. 2005;62(3):738–44.

    Article  PubMed  Google Scholar 

  67. Bath LE, Critchley HO, Chambers SE, et al. Ovarian and uterine characteristics after total body irradiation in childhood and adolescence : responses to sex steroid replacement. Br J Obstet Gynaecol. 1999;106:1265–72.

    Article  CAS  PubMed  Google Scholar 

  68. Salooja N, Szydlo RM, Socie G, Rio B, Chaterjee R, Ljungman P, Late eddects working party of the European group for Blood and Marrow transplantation, et al. Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. Lancet. 2001;358(9278):271–6.

    Article  CAS  PubMed  Google Scholar 

  69. Constine LS, Woolf PD, Cann D, Mick G, McCormick K, Raubertas RF, Rubin P. Hypothalamic pituitary dysfunction after radiotherapy for brain tumours. N Engl J Med. 1993;328(2):87–94.

    Article  CAS  PubMed  Google Scholar 

  70. Arbyn M, Simoens C, Goffin F, Noehr B, Bruinsma F. Treatment of cervical cancer precursors: influence of age, completeness of excision and cone depth on therapeutic failure, and on adverse obstetric outcomes. BJOG. 2011;118(10):1274–5. author reply 1275-1276

    Article  CAS  PubMed  Google Scholar 

  71. Schneider A, Erdemoglu E, Chiantera V, Reed N, Morice P, Rodolakis A, Denschlag D, Kesic V. Clinical recommendation radical trachelectomy for fertility preservation in patients with early stage cervical cancer. Inj J Gynaecol Cancer. 2012;33(4):659–66.

    Article  Google Scholar 

  72. Bruinsma FJ, Quinn MA. The risk of preterm birth following treatment for precancerous changes in the cervix: a systematic review and meta-analysis. BJOG. 2011;118(9):1031–41.

    Article  CAS  PubMed  Google Scholar 

  73. Cobo A, Garrido N, Pellicer A, Remohi J. Six years’ experience in ovum donation using vitrified oocytes: report of cumulative outcomes, impact of storage time, and development of a predictive model for oocyte survival rate. Fertil Steril. 2015;104(6):1426–34. e1421–1428

    Article  PubMed  Google Scholar 

  74. Doyle JO, Richter KS, Lim J, Stillman RJ, Graham JR, Tucker MJ. Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probablities for fertility preservation according to number of cryopreserved oocytes and age at retrieval. Fertil Steril. 2016;105(2):459–66.

    Article  PubMed  Google Scholar 

  75. Argyle CE, Harper JC, Davies MC. Oocyte cryopreservation: where are we now. Hum Reprod Update. 2016;22(4):440–9.

    Article  PubMed  Google Scholar 

  76. Druckenmiller S, Goldman KN, Labella PA, Fino ME, Bazzocchi A, Noyes N. Successful oocyte cryopreservation in reproductive aged cancer survivors. Obstet Gynecol. 2016;127(3):474–80.

    Article  CAS  PubMed  Google Scholar 

  77. Porcu E, Bazzocchi A, Notarangelo L, Paradisi R, Landolfo C, Venturoli S. Human oocyte cryopreservation in infertility and oncology. Curr Opin Endocrinol Diabetes Obes. 2008;15:529–35.

    Article  PubMed  Google Scholar 

  78. HFEA – Human Fertilisation and Embryology (1990) European Court of Human Rights judgment is http://hudoc.echr.coe.int/eng?i=001-80046

  79. Friedler S, Koc O, Gidoni Y, Raziel A. Ovarian response to stimulation for fertility preservation in women with malignant disease: a systematic review and meta-analysis.Fertil. Steril. 2012;97(1):125–33.

    Article  Google Scholar 

  80. Cakmak H, Rosen MP. Random-start ovarian stimulation in patients with cancer. Curr Opin Obstet Gynecol. 2015;27(3):215–21.

    Article  PubMed  Google Scholar 

  81. Donnez J, Dolmans MM. Ovarian cortex transplantation: 60 reported live births brings the success and worldwide expansion of the technique towards routine clinical practice. J Assist Reprod Genet. 2015;32(8):1167–70.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Rodriguez-Wallberg KA, Tanbo T, Tinkanen H, Thurin-Kjellberg A, Nedstrand E, Kitlinski ML, Macklon KT, Ernst E, Fedder J, Tiitinen A, Morin-Papunen L, Einarsson S, Jokimaa V, Hippeläinen M, Lood M, Gudmundsson J, Olofsson JI, Andersen CY. Ovarian tissue cryopreservation and transplantation among alternatives for fertility preservation in the Nordic countries- compliation of 20 years of multicenter experience. Acta Obstet Gynecol Scand. 2016;95(9):1015–26.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Jensen AK, Macklon KT, Fedder J, Ernst E, Humaidan P, Andersen CY. 86 successful births and 9 ongoing pregnancies worlwide in women transplanted with frozen thawed ovarian tissue: focus on birth and perinatal outcomes in 40 of these children. J Assist Reprod Genet. 2016;34(3):325–36.

    Article  PubMed  Google Scholar 

  84. Creux H, Monier P, Son WY, Tulandi T, Buckett W. Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstual cycle in women with cancer who require urgent gonadotoxic treamtent.Fertil. Steril. 2017;107(1):198–204.

    Article  Google Scholar 

  85. Uzelac PS, Delaney AA, Christensen GL, Bohler HC, Nakajima ST. (2015) liver birth following in vitro maturation of oocytes retrieved from extracorporeal ovarian tissue aspiration and embryocryopreservation for 5 years. Fertil Steril. 2015 Nov;104(5):1258–60.

    Article  PubMed  Google Scholar 

  86. Yin H, Jiang H, Kristensen SG, Andersen CY. Vitrification of in vitro matured oocytes collected from surplus ovarian medulla tissue resulting from fertility preservation of ovarian cortex tissue. J Assist Reprod Genet. 2016;33(6):741–6.

    Article  PubMed  PubMed Central  Google Scholar 

  87. Chen H, Li J, Cui T, Hu L. Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal women. Cochrane Database Syst Rev. 2011;9(11):CD008018.

    Google Scholar 

  88. Del Mastro L, Boni L, Michelotti A, Gamucci T, Olmeo N, Gori S, Giordano M, Garrone O, Pronzato P, Bighin C, Levaggi A, Giraudi S, Cresti N, Magnolfi E, Scotto T, Vecchio C, Venturini M. Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial. JAMA. 2011;306(3):269–76.

    PubMed  Google Scholar 

  89. Shen YW, Zhang XM, Lv M, Chen L, Qin TJ, Wang F, Yang J, Liu PJ, Yang J. Utility of gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a systematic review and meta-analysis. Onco Targets Ther. 2015;8:3349–59.

    Article  PubMed  PubMed Central  Google Scholar 

  90. Del Mastro L, Ceppi M, Poggio F, Bighin C, Peccatori F, Demeestere I, Levaggi A, Giraudi S, Lambertini M, D’Alonzo A, Canavese G, Pronzato P, Bruzzi P. Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials. Cancer Treat Rev. 2014;40(5):675–83.

    Article  PubMed  Google Scholar 

  91. Munhoz RR, Pereira AA, Sasse AD, Hoff PM, Traina TA, Hudis CA, Marques RJ. Gonadotropin-releasing hormone agonists for ovarian function preservation in premenopausal women undergoing chemotherapy for early-stage breast cancer: a systematic review and meta-analysis. JAMA Oncol. 2016;2(1):65–73.

    Article  PubMed  PubMed Central  Google Scholar 

  92. Demeestere I, Brice P, Peccatori FA, Kentos A, Dupuis J, Zachee P, Casasnovas O, Van Den Neste E, Dechene J, De Maertelaer V, Bron D, Englert Y. No evidence for the benefit of gonadotropin-releasing hormone agonist in preserving ovarian function and fertility in lymphoma survivors treated with chemotherapy: final long-term report of a prospective randomized trial. J Clin Oncol. 2016;34(22):2568–74. https://doi.org/10.1200/JCO.2015.65.8864. Epub 2016 May 23

    Article  CAS  PubMed  Google Scholar 

  93. Negri G, Herz M, Deola S, Piccin A, Casini M, Babich B, Tauber M, Messini S, Marucci MR, Vittadello F. Abnormal cervical cytology after allogeneic bone marrow transplantation. Am J Clin Pathol. 2014;142(2):222–6.

    Article  PubMed  Google Scholar 

  94. HFEA ACT (1990) https://embryo.asu.edu/pages/human-fertilisation-and-embryology-act-199

  95. Barbera L, Zwaal C, Elterman D, McPherson K, Wolfman W, Katz A, Matthew A. Interventions to address sexual problems in people with cancer. Curr Oncol. 2017;24(3):192–200.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. Quinn MM, Letourneau JM, Rosen MP. Contraception after cancer treatment: describing methods, counseling, and unintended pregnancy risk. Contraception. 2014;89(5):466–71.

    Article  PubMed  Google Scholar 

  97. Soanes L, White ID. Sexual consequences of cancer and its treatment in adolescents and young adults. In cancer in adolescents and young adults. Springer International Publishing 2017, pp. 603–631.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Guy’s and St. Thomas NHS Foundation Trust, London, UK

    Nivedita Reddy

  2. University Hospitals Bristol NHS Foundation Trust, Bristol, UK

    Caroline L. Furness

  3. University College London Hospitals (UCLH) NHS Foundation Trust, London, UK

    Melanie C. Davies

Authors
  1. Nivedita Reddy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Caroline L. Furness
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Melanie C. Davies
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nivedita Reddy .

Editor information

Editors and Affiliations

  1. Royal Marsden Hospital, Sutton, Surrey, United Kingdom

    Julia Chisholm

  2. University College Hospital, London, United Kingdom

    Rachel Hough

  3. University College Hospital, London, United Kingdom

    Louise Soanes

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Reddy, N., Furness, C.L., Davies, M.C. (2018). Fertility in the Adolescent and Young Adult Patient with Cancer. In: Chisholm, J., Hough, R., Soanes, L. (eds) A Practical Approach to the Care of Adolescents and Young Adults with Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-66173-5_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-66173-5_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-66172-8

  • Online ISBN: 978-3-319-66173-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation